Orthofix Medical Inc.

Equities

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
13.22 USD +1.07% Intraday chart for Orthofix Medical Inc. +0.30% -1.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer CI
Orthofix Medical Inc. Announces Board Resignation CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024 CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024 CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Orthofixan Signs Deal to Distribute BoneMRI Imaging Software in US MT
Orthofix Announces Commercial Partnership with MRIguidance CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q4 Revenue $200.3M MT
Orthofix Medical Inc. Names Massimo Calafiore as President and Member of the Board of Directors Effective Immediately CI
Orthofix Medical Inc. Names Massimo Calafiore as Chief Executive Officer CI
Orthofix Medical Inc. Appoints Julie Andrews as Chief Financial Officer CI
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 1000 CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600 Health Care CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600 CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P Composite 1500 CI
Orthofix Medical Inc. Announces Board Changes CI
Engine Capital Management Enters into a Cooperation Agreement with Orthofix Medical CI
Uber Technologies, Jabil, Builders First Source to Join S&P 500 on Dec. 18, Other Index Changes MT
Chart Orthofix Medical Inc.
More charts
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.08 USD
Average target price
18.47 USD
Spread / Average Target
+41.18%
Consensus
  1. Stock Market
  2. Equities
  3. OFIX Stock
  4. News Orthofix Medical Inc.
  5. Orthofix Medical : Says First Implant Done in Study of Artificial Cervical Disc